ERBB2 and breast carcinoma: Additionally, in breast cancer, high mRNA and protein ISG15 expression are associated with lymphovascular invasion (LVI), higher histological grade, larger tumor size, hormonal receptor negativity, HER2 positivity, HER2-enriched breast cancer subtypes, immune markers (CD8, FOXP3, and CD68), and with poor patient outcome [152].